YSOPIA Bioscience (formerly known as LNC Therapeutics) is a biotech company specializing in gut microbiome-based drug discovery. It is engaged in exploring and optimizing single bacterial strains to deliver microbiome-based therapies for obesity, metabolic disorders, inflammation, and neurology.